NO924166L - Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav - Google Patents

Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav

Info

Publication number
NO924166L
NO924166L NO92924166A NO924166A NO924166L NO 924166 L NO924166 L NO 924166L NO 92924166 A NO92924166 A NO 92924166A NO 924166 A NO924166 A NO 924166A NO 924166 L NO924166 L NO 924166L
Authority
NO
Norway
Prior art keywords
radical
substituted
phenyl
alkyl
radicals
Prior art date
Application number
NO92924166A
Other languages
English (en)
Norwegian (no)
Other versions
NO924166D0 (no
Inventor
Gerhard Scheffler
Ilona Fleischhauer
Bernhard Kutscher
Juergen Engel
Stefan Szelenyi
Ulrich Werner
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO924166D0 publication Critical patent/NO924166D0/no
Publication of NO924166L publication Critical patent/NO924166L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
NO92924166A 1991-10-31 1992-10-29 Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav NO924166L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4135910 1991-10-31

Publications (2)

Publication Number Publication Date
NO924166D0 NO924166D0 (no) 1992-10-29
NO924166L true NO924166L (no) 1993-05-03

Family

ID=6443832

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924166A NO924166L (no) 1991-10-31 1992-10-29 Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav

Country Status (20)

Country Link
US (1) US5354750A (ko)
EP (1) EP0539805B1 (ko)
JP (1) JPH05222002A (ko)
KR (1) KR930007914A (ko)
CN (1) CN1071916A (ko)
AT (1) ATE157656T1 (ko)
AU (1) AU660726B2 (ko)
BR (1) BR9204187A (ko)
CA (1) CA2081819A1 (ko)
DE (2) DE59208852D1 (ko)
DK (1) DK0539805T3 (ko)
ES (1) ES2108066T3 (ko)
FI (1) FI924934A (ko)
GR (1) GR3025141T3 (ko)
HU (2) HUT62866A (ko)
IL (1) IL103601A0 (ko)
MX (1) MX9206245A (ko)
NO (1) NO924166L (ko)
TW (1) TW211563B (ko)
ZA (1) ZA928420B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226573D0 (en) * 1992-12-21 1993-02-17 Ici Plc Heterocyclic compounds
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US20020028813A1 (en) * 1997-09-03 2002-03-07 Paul F. Jackson Thioalkyl compounds, methods, and compositions for inhibiting parp activity
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
US3882119A (en) * 1970-01-27 1975-05-06 Lepetit Spa Tetracyclic substituted phthalazine compounds
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
JPH01261386A (ja) * 1988-04-11 1989-10-18 Nisshin Flour Milling Co Ltd 新規な２―ピリジルメチルチオ誘導体及びそれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
BR9204187A (pt) 1993-05-04
ES2108066T3 (es) 1997-12-16
ZA928420B (en) 1993-05-14
EP0539805B1 (de) 1997-09-03
HU211863A9 (en) 1995-12-28
CN1071916A (zh) 1993-05-12
ATE157656T1 (de) 1997-09-15
IL103601A0 (en) 1993-03-15
NO924166D0 (no) 1992-10-29
MX9206245A (es) 1993-05-01
AU2747192A (en) 1993-05-06
JPH05222002A (ja) 1993-08-31
CA2081819A1 (en) 1993-05-01
DK0539805T3 (da) 1998-03-23
TW211563B (ko) 1993-08-21
US5354750A (en) 1994-10-11
KR930007914A (ko) 1993-05-20
HU9203431D0 (en) 1993-01-28
EP0539805A1 (de) 1993-05-05
DE4234933A1 (de) 1993-05-06
FI924934A (fi) 1993-05-01
HUT62866A (en) 1993-06-28
FI924934A0 (fi) 1992-10-30
AU660726B2 (en) 1995-07-06
DE59208852D1 (de) 1997-10-09
GR3025141T3 (en) 1998-02-27

Similar Documents

Publication Publication Date Title
NO924166L (no) Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav
DE69406649T2 (de) N-alkyl-2-substituierte atp-analoge
MY107756A (en) Piperazine derivatives.
SE8503888L (sv) Heterocykliska derivat
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
NO166129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler.
LU90758I2 (fr) Almotriptan et ses sels pharmaceutiquement acceptables
EP0529452A3 (de) 1,7-anellierte 2-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DK0461986T3 (da) Hexahydroazepinderivater, en fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse
IS3828A (is) Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar
NO162234C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere.
HUT37797A (en) Process for production of tetrahydro-tieno-piridinderivatives and medical preparatives containing of such compounds
NO982927L (no) Biologisk aktive benzotiazolon etanaminer
DK0387489T3 (da) Anvendelse af 2,2,6,6-tetramethyl-4-aminopiperidinamider som fungicider
DK432086D0 (da) Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
FI894125A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister